Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Willman

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Leukemia|June 9, 1999
Methylation analysis of the human multidrug resistance 1 gene in normal and leukemic hematopoietic cellsK B Fryxell, S B McGee, D K Simoneaux, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|September 1, 1994
The presence of bcl-1 and bcl-2 gene rearrangements in diffuse small cleaved-cell lymphoma. A disease with diverse molecular and immunophenotypic findingsC P Leith, C L Willman, C M Spier, et al.
Leukemia Research|January 16, 2003
Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpressionD L Stirewalt, F R Appelbaum, C L Willman, et al.
American Journal of Clinical Pathology|January 1, 1990
Aggressive jejunal lymphoma of large granular lymphocytes. Immunohistochemical, ultrastructural, molecular, and DNA content analysisT A Longacre, M B Listrom, J H Spigel, et al.
Blood|April 21, 2001
Methylation profiling in acute myeloid leukemiaM Toyota, K J Kopecky, M O Toyota, et al.
Leukemia Research|January 4, 2001
Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosisS M Garrido, J J Cooper, F R Appelbaum, et al.
Leukemia|December 22, 1999
Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31)W B Green, M L Slovak, I M Chen, et al.
Blood|August 15, 1990
N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significanceJ P Radich, K J Kopecky, C L Willman, et al.
Leukemia|July 30, 2003
Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group studyM J Borowitz, D J Pullen, J J Shuster, et al.
Genomics|January 1, 1995
Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell lineM Saito, K Helin, M B Valentine, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Leukemia|June 9, 1999
Methylation analysis of the human multidrug resistance 1 gene in normal and leukemic hematopoietic cellsK B Fryxell, S B McGee, D K Simoneaux, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|September 1, 1994
The presence of bcl-1 and bcl-2 gene rearrangements in diffuse small cleaved-cell lymphoma. A disease with diverse molecular and immunophenotypic findingsC P Leith, C L Willman, C M Spier, et al.
Leukemia Research|January 16, 2003
Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpressionD L Stirewalt, F R Appelbaum, C L Willman, et al.
American Journal of Clinical Pathology|January 1, 1990
Aggressive jejunal lymphoma of large granular lymphocytes. Immunohistochemical, ultrastructural, molecular, and DNA content analysisT A Longacre, M B Listrom, J H Spigel, et al.
Blood|April 21, 2001
Methylation profiling in acute myeloid leukemiaM Toyota, K J Kopecky, M O Toyota, et al.
Leukemia Research|January 4, 2001
Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosisS M Garrido, J J Cooper, F R Appelbaum, et al.
Leukemia|December 22, 1999
Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31)W B Green, M L Slovak, I M Chen, et al.
Blood|August 15, 1990
N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significanceJ P Radich, K J Kopecky, C L Willman, et al.
Leukemia|July 30, 2003
Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group studyM J Borowitz, D J Pullen, J J Shuster, et al.
Genomics|January 1, 1995
Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell lineM Saito, K Helin, M B Valentine, et al.
Pageof 9